Rescue of dopamine transporter function in hypoinsulinemic rats by a D 2 receptor-ERK-dependent mechanism

Journal of Neuroscience

Volumn 32, Issue 8, 2012, Pages 2637-2647

  Anthony Owens, W ^a   Williams, Jason M ^b,c   Saunders, Christine ^b   Avison, Malcolm J ^b,c   Galli, Aurelio ^b   Daws, Lynette C ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RACLOPRIDE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BOLD SIGNAL; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLUCOSE BLOOD LEVEL; HYPOINSULINEMIA; IMMUNOBLOTTING; IMMUNOREACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SYNAPTOSOME;

AMPHETAMINE; ANALYSIS OF VARIANCE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; BRAIN; BRAIN MAPPING; CORPUS STRIATUM; DIABETES MELLITUS, EXPERIMENTAL; DOPAMINE; DOPAMINE AGENTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; ENZYME INHIBITORS; HYPOGLYCEMIC AGENTS; IMAGE PROCESSING, COMPUTER-ASSISTED; INSULIN; MAGNETIC RESONANCE IMAGING; MALE; MAP KINASE SIGNALING SYSTEM; OXYGEN; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2;

EID: 84863116305     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3759-11.2012     Document Type: Article

References (50)

1. Batchelor M, Schenk JO (1998) Protein kinase A activity may kinetically upregulate the striatal transporter for dopamine. J Neurosci 18:10304-10309.
2. Bolan EA, Kivell B, Jaligam V, Oz M, Jayanthi LD, Han Y, Sen N, Urizar E, Gomes I, Devi LA, Ramamoorthy S, Javitch JA, Zapata A, Shippenberg TS (2007) D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism. Mol Pharmacol 71:1222-1232.
3. Callaghan PD, Irvine RJ, Daws LC (2005) Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute paramethoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry. Neurochem Int 47:350-361.
4. Carr KD, Kim G-Y, Cabeza de Vaca S (2000) Hypoinsulinemia may mediate the lowering of self-administration thresholds by food restriction and streptozotocin-induced diabetes. Brain Res 863:160-168.
5. Carvelli L, Morón JA, Kahlig KM, Ferrer JV, Sen N, Lechleiter JD, Leeb-Lunberg LM, Merrill G, Lafer EM, Ballou LM, Shippenberg TS, Javitch JA, Lin RZ, Galli A (2002) PI3-kinase regulation of dopamine uptake. J Neurochem 81:859-869.
6. Cass WA, Gerhardt GA (1994) Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake. Neurosci Lett 185:52-55.
7. Chen YC, Galpern WR, Brownell AL, Matthews RT, Bogdanov M, Isacson O, Keltner JR, Beal MF, Rosen BR, Jenkins BG (1997) Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data. Magn Reson Med 38:389-398.
8. Chen YI, Brownell AL, Galpern W, Isacson O, Bogdanov M, Beal MF, Livni E, Rosen BR, Jenkins BG (1999) Detection of dopaminergic cell loss and neural transplantation using pharmacological MRI, PET and behavioral assessment. Neuroreport 10:2881-2886.
9. Choe ES, Wang JQ (2002) CaMKII regulates amphetamine-induced ERK1/2 phophorylation in striatal neurons. Neuroreport 13:1013-1016.
10. Clausing P, Gough B, Holson RR, Slikker W, Bowyer JF (1995) Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects. J Pharmacol Exp Ther 274:614-621.
11. Daws LC, Avison MJ, Robertson SD, Niswender KD, Galli A, Saunders C (2011) Insulin signaling and addiction. Neuropharmacology 61:1123-1128.
12. Dickinson SD, Sabeti J, Larson GA, Giardina K, Rubinstein M, Kelly MA, Grandy DK, Low MJ, Gerhardt GA, Zahniser NR (1999) Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J Neurochem 72:148-156.
13. Ericson H, Radesater AC, Servin E, Magnusson O, Mohringe B (1996) Effects of intermittent and continuous subchronic administration of raclopride on motor activity, dopamine turnover and receptor occupancy in the rat. Pharmacol Toxicol 79:277-286.
14. Figlewicz DP, Benoit SC (2009) Insulin, leptin, and food reward: update 2008. Am J Physiol Regul Integr Comp Physiol 296:R9-R19.
15. Figlewicz DP, MacDonald NA, Sipols AJ (2007) Modulation of food reward by adiposity signals. Physiol Behav 91:473-478.
16. Galipeau DM, Yao L, McNeill JH (2002) Relationship among hyperinsulinemia, insulin resistance, and hypertension is dependent on sex. Am J Physiol Heart Circ Physiol 283:562-567.
17. Garcia BG, Wei Y, Morón JA, Lin RZ, Javitch JA, Galli A (2005) Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution. Mol Pharmacol 68:102-109.
18. Gruetter R, Ugurbil K, Seaquist ER (2000) Effect of acute hyperglycemia on visual cortical activation as measured by functional MRI. J Neurosci Res 62:279-285.
19. Gulley JM, Doolen S, Zahniser NR (2002) Brief, repeated exposure to substrates down-regulates dopamine transporter function in Xenopus oocytes in vitro and rat dorsal striatum in vivo. J Neurochem 83:400-411.
20. Izzo E, Martin-Fardon R, Koob GF, Weiss F, Sanna PP (2002) Neural plasticity and addiction: PI3-kinase and cocaine behavioral sensitization. Nat Neurosci 5:1263-1264.
21. Kuhn CM, Schanberg SM (1978) Metabolism of amphetamine after acute and chronic administration to the rat. J Pharmacol Exp Ther 207:544-554.
22. Lee FJ, Pei L, Moszczynska A, Vukusic B, Fletcher PJ, Liu F (2007) Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor. EMBO J 26:2127-2136.
23. Lim DK, Lee KM, Ho IK (1994) Changes in central dopaminergic systems in the streptozotocin-induced diabetic rats. Arch Pharm Res 17:398-404.
24. Lozovsky D, Saller CF, Kopin IJ (1981) Dopamine receptor binding is increased in diabetic rats. Science 214:1031-1033.
25. Mayfield RD, Zahniser NR (2001) Dopamine D2 receptor regulation of the dopamine transporter expressed in Xenopus laevis oocytes is voltageindependent. Mol Pharmacol 59:113-121.
26. Meiergerd SM, Patterson TA, Schenk JO (1993) D2 receptors may modulate the function of the striatal transporter for dopamine: kinetic evidence from studies in vitro and in vivo. J Neurochem 61:764-767.
27. Moro ́n JA, Zakharova I, Ferrer JV, Merrill GA, Hope B, Lafer EM, Lin ZC, Wang JB, Javitch JA, Galli A, Shippenberg TS (2003) Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity. J Neurosci 23:8480-8488.
28. Murzi E, Contreras Q, Teneud L, Valecillos B, Parada MA, De Parada MP, Hernandez L (1996) Diabetes decreases limbic extracellular dopamine in rats. Neurosci Lett 202:141-144.
29. Niswender KD, Daws LC, Avison MJ, Galli A (2011) Insulin regulation of monoamine signaling: pathway to obesity. Neuropsychopharmacology 36:359-360.
30. Owens WA, Sevak RJ, Galici R, Chang X, Javors MA, Galli A, France CP, Daws LC (2005) Deficits in dopamine clearance and locomotion in hypoinsulinemic rats unmask novel modulation of dopamine transporters by amphetamine. J Neurochem 94:1402-1410.
31. Palmiter RD (2007) Is dopamine a physiologically relevant mediator of feeding behavior? Trends Neurosci 30:375-381.
32. Palmiter RD (2008) Dopamine signaling in the dorsal striatum is essential for motivated behaviors: lessons from dopamine-deficient mice. AnnN Y Acad Sci 1129:35-46.
33. Pandey SC (1998) Neuronal signaling systems and ethanol dependence. Mol Neurobiol 17:1-15.
34. Patterson TA, Brot MD, Zavosh A, Schenk JO, Szot P, Figlewicz DP (1998) Food deprivation decreasesmRNAand activity of the rat dopamine transporter. Neuroendocrinology 68:11-20.
35. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates New York: Academic.
36. Price DA, Owens WA, Gould GG, Frazer A, Roberts JL, Daws LC, Guiffrida A (2007) CB1-independent inhibition of dopamine transporter activity by cannabinoids in mouse dorsal striatum. J Neurochem 101:389-396.
37. Russo SJ, Bolanos CA, Theobald DE, DeCarolis NA, Renthal W, Kumar A, Winstanley CA, Renthal NE, Wiley MD, Self DW, Russell DS, Neve RL, Eisch AJ, Nestler EJ (2007) IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates. Nat Neurosci 10:93-99.
38. Serri O, Renier G, Somma M (1985) Effects of alloxan-induced diabetes on dopaminergic receptors in rat striatum and anterior pituitary. Horm Res 21:95-101.
39. Sevak RJ, Owens WA, Koek W, Galli A, Daws LC, France CP (2007a) Evidence for D2 receptor mediation of amphetamine-induced normalization of locomotion and dopamine transporter function in hypoinsulinemic rats. J Neurochem 101:151-159.
40. Sevak RJ, Koek W, Galli A, France CP (2007b) Insulin replacement restores the behavioral effects of quinpirole and raclopride in streptozotocintreated rats. J Pharmacol Exp Ther 320:1216-1223.
41. Shi X, McGinty JF (2006) Extracellular signal-regulated mitogen-activated protein kinase inhibitors decrease amphetamine-induced behavior and neuropeptide gene expression in the striatum. Neuroscience 138:1289-1298.
42. Shiflett MW, Balleine BW (2011) Contributions of ERK signaling in the striatum to instrumental learning and performance. Behav Brain Res 218:240-247.
43. Szkudelski T (2001) The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50:537-546.
44. Trulson ME, Himmel CD (1983) Decreased brain dopamine synthesis rate and increased [3H]spiroperidol binding in streptozotocin-diabetic rats. J Neurochem 40:1456-1459.
45. Valjent E, Pascoli V, Svenningsson P, Paul S, Enslen H, Corvol JC, Stipanovich A, Caboche J, Lombroso PJ, Nairn AC, Greengard P, Hervé D, Girault JS (2005) Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc Natl Acad Sci U S A 102:491-496.
46. Wei Y, Williams JM, Dipace C, Sung U, Javitch JA, et al (2007) Dopamine transporter activity mediates amphetamine-induced inhibition of Akt through a Ca2+/calmodulin-dependent kinase II-dependent mechanism. Mol Pharmacol 71:835-842.
47. Williams JM, Owens WA, Turner GH, Saunders C, Dipace C, Blakely RD, France CP, Gore JC, Daws LC, Avison MJ, Galli A (2007) Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine. PLoS Biol 5:2369-2378.
48. Williams JM, Milatovic D, Gore JC, Aschner M, Avison MJ (2010) Chronic exposure to manganese alters brain responses to amphetamine: a pharmacological magnetic resonance imaging study. Toxicol Sci 114:310-322.
49. Zahniser NR, Larson GA, Gerhardt GA (1999) In vivo dopamine clearance rate in rat striatum: regulation by extracellular dopamine concentration and dopamine transporter inhibitors. J Pharmacol Exp Ther 289:266-277.
50. Zapata A, Kivell B, Han Y, Javitch JA, Bolan EA, Kuraguntla D, Jaligam V, Oz M, Jayanthi LD, Samuvel DJ, Ramamoorthy S, Shippenberg TS (2007) Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors. J Biol Chem 282:35842-35854.